DaVita Financial Statements
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DaVita revenue and earnings
In fiscal 2025, DaVita generated $13.64 billion in revenue, up 6.5% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $746.8 million (-20.2% year over year), for a net margin of 5.5% versus a median of 6.7% in the prior 5 years. Operating margin was 15.0%.
Diluted earnings per share came in at $9.84, down from $10.73. Over the last 5 fiscal years, DVA's revenue has grown at a 3.4% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
DaVita income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.64B | 12.82B | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 10.71B |
| Revenue growth (YoY) | +6.46% | +5.56% | +4.57% | -0.08% | +0.59% | +1.42% | -0.14% | +4.86% | +1.58% | +7.27% |
| Operating Income | 2.04B | 2.09B | 1.60B | 1.34B | 1.80B | 1.69B | 1.64B | 1.53B | 1.81B | 2.03B |
| Interest Expense | 539.92M | 435.20M | 373.95M | 339.25M | 267.05M | 282.93M | 419.64M | 461.90M | 406.34M | 394.01M |
| Other Income (Expense) | -102.69M | -69.81M | -19.18M | -15.77M | 6.38M | 16.76M | 29.35M | 10.09M | 17.66M | 7.51M |
| Pretax Income | 1.35B | 1.53B | 1.18B | 966.28M | 1.52B | 1.32B | 1.20B | 1.05B | 1.40B | 1.62B |
| Income Tax | 293.11M | 279.66M | 220.12M | 198.09M | 306.73M | 313.93M | 279.63M | 258.40M | 323.86M | 431.76M |
| Net Income | 746.80M | 936.34M | 691.53M | 560.40M | 978.45M | 773.64M | 810.98M | 159.39M | 663.62M | 879.87M |
| Net Income growth (YoY) | -20.24% | +35.40% | +23.40% | -42.73% | +26.47% | -4.60% | +408.79% | -75.98% | -24.58% | +226.20% |
| EPS (Basic) | 10.06 | 11.02 | 7.62 | 6.03 | 9.30 | 6.46 | 5.29 | 0.93 | 3.52 | 4.36 |
| EPS (Diluted) | 9.84 | 10.73 | 7.42 | 5.85 | 8.90 | 6.31 | 5.27 | 0.92 | 3.47 | 4.29 |
| Shares Outstanding (Basic) | 74.23M | 84.99M | 90.79M | 92.99M | 105.23M | 119.80M | 153.18M | 170.79M | 188.63M | 201.64M |
| Shares Outstanding (Diluted) | 75.89M | 87.27M | 93.18M | 95.83M | 109.95M | 122.62M | 153.81M | 172.37M | 191.35M | 204.90M |
| EBITDA | 2.75B | 2.81B | 2.34B | 2.06B | 2.47B | 2.31B | 2.24B | 2.10B | 2.36B | 2.52B |
| Operating Margin | 14.98% | 16.31% | 13.20% | 11.53% | 15.47% | 14.67% | 14.43% | 13.38% | 16.67% | 18.96% |
| Net Margin | 5.47% | 7.31% | 5.70% | 4.83% | 8.42% | 6.70% | 7.12% | 140.00% | 6.10% | 8.22% |
This table shows 10 annual periods of DaVita's income statement, from FY 2025 back to FY 2016, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow DVA's reporting calendar. What is a income statement?